Comments

Oramed Pharmaceuticals Stock Guidance

ORMPNASDAQ
Logo brought to you by Benzinga Data
Trade with Public
Trade with Public
$3.19
0.123.91%
Last update: Dec 15, 8:55 AM
OverviewNewsEarningsOptionsAnalyst RatingsInsider TradesShort InterestGovernment TradesStock Report

Oramed Pharmaceuticals Stock Guidance | NASDAQ:ORMP | Benzinga

Oramed Pharmaceuticals issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

Get Alert
Oramed Pharmaceuticals Inc (ORMP) does not provide guidance data

FAQ

Q

What is the most recent guidance for Oramed Pharmaceuticals (ORMP)?

A

There have been no specific sales or earnings guidance reported for Oramed Pharmaceuticals in recent months.

Browse guidance and forecast on all stocks.

People Also Watch

Atea Pharmaceuticals Inc
NASDAQ:AVIR
$3.17
0.48%
MediWound Ltd
NASDAQ:MDWD
$19.00
-0.26%
Rani Therapeutics Holdings Inc
NASDAQ:RANI
$1.38
2.61%
Incannex Healthcare Inc
NASDAQ:IXHL
$0.42
-1.47%
Anebulo Pharmaceuticals Inc
NASDAQ:ANEB
$2.26
-1.31%
No data available
High Tide Inc
NASDAQ:HITI
$2.85
-2.57%
Sol-Gel Technologies Ltd
NASDAQ:SLGL
$39.01
%
No data available
Milestone Pharmaceuticals Inc
NASDAQ:MIST
$2.44
1.06%
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2025 Benzinga | All Rights Reserved